Global Health Share Price

Conference Call with Global Health Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

• Trendlyne
• 1 week 2 days ago

Healthcare Facilities company Global Health announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Income: For Q4FY26, the consolidated total income stood at Rs 11,957.89 million, representing a growth of 4.63% QoQ compared to Rs 11,428.29 million in Q3FY26 and an increase of 25.32% YoY from Rs 9,541.77 million in Q4FY25. For the full year FY26, total income reached Rs 45,088.60 million compared to Rs 37,712.92 million in FY25, a YoY growth of 19.56%. Revenue from Operations: Consolidated revenue for Q4FY26 was Rs 11,590.47 million, up 3.39% QoQ from Rs 11,210.94 million and up 24.46% YoY from Rs 9,312.52 million in Q4FY25. Annual revenue for FY26 stood at Rs 44,102.66 million, reflecting a 19.44% increase over FY25. Profit After Tax (PAT): The company reported a consolidated PAT of Rs 1,416.53 million in Q4FY26, showing a growth of 49.06% QoQ from Rs 950.33 million and a 39.73% YoY increase from Rs 1,013.78 million in Q4FY25. For the full year FY26, PAT was Rs 5,540.68 million compared to Rs 4,813.18 million in FY25, a growth of 15.11%. Earnings Per Share (EPS): Basic EPS for Q4FY26 stood at Rs 5.36, compared to Rs 3.54 in Q3FY26 and Rs 3.77 in Q4FY25. For the full year FY26, basic EPS reached Rs 20.71 compared to Rs 17.92 in FY25. Standalone Financial Highlights: Total Income: Standalone total income for Q4FY26 was Rs 9,964.34 million, an increase of 3.28% QoQ from Rs 9,648.29 million and a 20.27% YoY growth from Rs 8,285.34 million in Q4FY25. Annual income for FY26 stood at Rs 38,157.86 million compared to Rs 32,949.55 million in FY25. Revenue from Operations: Standalone revenue for Q4FY26 reached Rs 9,606.29 million, up 2.18% QoQ from Rs 9,401.65 million and up 19.65% YoY from Rs 8,028.68 million in Q4FY25. Full-year standalone revenue for FY26 was Rs 37,093.78 million. Profit After Tax (PAT): Standalone PAT for Q4FY26 was Rs 1,241.31 million, representing a growth of 55.34% QoQ from Rs 799.07 million and a 32.89% YoY increase from Rs 934.12 million in Q4FY25. For the full year FY26, standalone PAT was Rs 4,962.01 million compared to Rs 4,615.28 million in FY25. Business Highlights: Segment Performance: The Company has identified healthcare services as its single business segment. Dividend: The Board of Directors recommended a final dividend of Rs 0.50 (25%) per Equity Share of face value Rs 2 each for the financial year ended March 31, 2026. Hospital Expansion: The company executed a definitive agreement for a 400-bed multi-specialty hospital in Varanasi, Uttar Pradesh, under a built-to-suit and lease arrangement. Subsequent to FY26, a Business Transfer Agreement (BTA) was signed to acquire a 79-bed Advanced Super Speciality Hospital in Indore, primarily engaged in oncology services. Exceptional Items: The full-year results for FY26 include a net exceptional gain of Rs 10.21 million (Consolidated) and a net exceptional loss of Rs 3.77 million (Standalone). This includes the reversal of interest liability on Export Promotion Capital Goods (EPCG) of Rs 195.92 million, reversal of stamp duty on merger of Rs 159.85 million, and an incremental impact of Rs 365.98 million (Consolidated) / Rs 352.00 million (Standalone) due to new Labour Codes. Personnel Changes: Appointment of Mr. Kedar Ashok Apte as ‘Chief Marketing & Growth Officer’ and Mr. Jagdeep Singh as ‘General Counsel’ (designated as SMPs) w.e.f. May 14, 2026. Resignation of Ms. Richa Singh (SMP) w.e.f. May 20, 2026. Result PDF

• Trendlyne
• 1 week 3 days ago

Addressing undernutrition could prevent up to 2.3 million tuberculosis cases worldwide, representing 23.7 per cent of infections among adults in 2023, according to a modelling study published in The Lancet Global Health journal. India could have seen the highest reduction in tuberculosis (TB) cases if undernutrition was addressed, followed by Indonesia, the Philippines and Pakistan, researchers, including those from London School of Hygiene and Tropical Medicine, estimated. "We estimated that eliminating moderate-to-severe undernutrition could avert 14 million tuberculosis episodes globally, representing 14.6 per cent of global adult incidence in 2023, while eliminating all undernutrition could avert 2.3 million episodes, representing a reduction in global tuberculosis incidence of 23.7 per cent," the authors wrote. The findings highlight the urgent need to scale up population-level nutritional interventions, social and health benefits from which could extend beyond tuberculosis, ..

• Business Standard
• 1 week 5 days ago